Pharmaceutical holding Nacimbio of Rostec State Corporation will create new production facilities at NPO Microgen subsidiaries in Ufa, Perm and Tomsk.
Read more
Microgen-developed drug Relatox® became available for Uzbek patients.
Read more.jpg)
In the first quarter of 2021, Scientific and Production Association Microgen increased exports of drug products to Uzbekistan by over 50 percent as compared to the same period of the last year.
Read more
In April 2021, a partnership agreement between NPO Microgen and NASKI (National Association of the Specialists in Control of Infections) was signed for raising awareness among the Russian Federation population of the benefits of preventive vaccination.
Read more
Within the partnership, a new vaccine production will be opened and release of blood plasma-based drugs including COVID-globulin for the coronavirus infection treatment will be arranged in Perm.
Read more
Microgen announced the registration of bivalent polysaccharide vaccine for the prevention of meningococcal infection by the Ministry of Health of the Russian Federation.
Read more
